immunotherapy

(redirected from immunotherapies)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to immunotherapies: adoptive immunotherapy, Immunotherapeutics

im·mu·no·ther·a·py

 (ĭm′yə-nō-thĕr′ə-pē, ĭ-myo͞o′-)
n. pl. im·mu·no·ther·a·pies
Treatment of disease by inducing, enhancing, or suppressing an immune response.

im′mu·no·ther′a·peu′tic (-pyo͞o′tĭk) adj.
im′mu·no·ther′a·pist n.

immunotherapy

(ˌɪmjʊnəʊˈθɛrəpɪ)
n
(Medicine) med the treatment of disease by stimulating the body's production of antibodies
immunotherapeutic adj

im•mu•no•ther•a•py

(ˌɪm yə noʊˈθɛr ə pi, ɪˌmyu-)

n., pl. -pies.
treatment designed to produce immunity to a disease or enhance the resistance of the immune system to an active disease process, as cancer.
[1905–10]
im`mu•no•ther`a•peu′tic (-ˈpyu tɪk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunotherapy - therapy designed to produce immunity to a disease or to enhance resistance by the immune system
therapy - (medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
Translations
imunoterapie

immunotherapy

[ˌɪmjʊnəʊˈθerəpɪ] Ninmunoterapia f

immunotherapy

[ˌɪmjʊnəʊˈθɛrəpɪ] nimmunoterapia

im·mu·no·ther·a·py

n. inmunoterapia, inmunización pasiva del paciente por medio de anticuerpos preformados (suero o gamma globulina).

immunotherapy

n inmunoterapia
References in periodicals archive ?
Immunotherapies are used for limited number of cancer treatment mostly haematological, but they show better results where other therapy is not effective.
There is a lot of research going on (some of which is currently funded by the Cornell Feline Health Center) both to find ways to increase the number of patients that respond to immunotherapies and to identify biomarkers that will predict which patients will respond," says oncologist Kelly R.
"There is a lot of research going on both to find ways to increase the number of patients that respond to immunotherapies and to identify biomarkers that will predict which patients will respond.
Food and Drug Administration, but in recent years, sublingual immunotherapies have proven effective.
Elpiscience is developing next generation cancer immunotherapies, and Bio-Techne, a global provider of molecular diagnostics, aim to expand mutual capabilities under the alliance in the field of cancer immunotherapy.
According to the company, AGI-134 is a synthetic alpha-Gal glycolipid in development for solid tumours that is highly differentiated from other cancer immunotherapies. Binding of anti-Gal antibodies to the treated tumors results in activation of the complement cascade, which destroys the tumour cells and creates a pro-inflammatory tumor microenvironment that induces a systemic, specific anti-tumour (vaccine) response to the patient's own tumour neo-antigens.
"We have already used these cellular immunotherapies to treat different types of cancer and viral infections.
M2 EQUITYBITES-October 10, 2018-eTheRNA immunotherapies opens Belgium mRNA facility
Atara Biotherapeutics announced that it has entered into a strategic collaboration with Moffitt Cancer Center to develop multi-targeted chimeric antigen receptor T-cell, or CAR T, immunotherapies for patients with AML and B-cell malignancies.
See Table 1 for approved immunotherapies with classification and cancer type.
This gathering of pharma/biopharma and academia professionals working in the field of Immuno-Oncology will highlight key topics like Neoantigen in personalized Cancer Immunotherapy, Immune Checkpoint Inhibitors and Combinations (PD-1, PD-L1, PD-L4), Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators), Neoantigen Discovery by Next-Generation Sequencing, Biomarkers and Cancer Vaccines, CAR-T cell therapy, Dendritic Cell Therapy, Microbiome in Cancer Immunotherapy (Targets and Challenges), Oncolytic viruses, Tumour associated Macrophages as treatment in IO, Technologies for personalized TCR engineered cancer immunotherapies and Tumour microenvironment.